SRX Global Inc.
SRXH
Positions held
Your positionsSRXH isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $28.26M | Enterprise value | -$17.70M | Trailing P/E | 0.02 | Forward P/E | — |
| PEG | — | Price / book | 0.20 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | -94.4% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | 0.00 | Free cash flow | — | Analyst recommendation | none | Mean target | — |
| 52w high | $42.60 | 52w low | $0.96 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4M | $3.4M | $2.8M | -$34.5M | — | $7.2M |
| Op margin | -94.4% | -52.9% | -135.0% | -52.3% | — | -15.2% |
| Net income | -$4.1M | -$6.4M | -$8.6M | -$15.3M | — | -$1.0M |
| Gross margin | 26.7% | 37.1% | 37.5% | 25.4% | — | 33.3% |
| Gross profit | $0.9M | $1.3M | $1.1M | -$8.8M | — | $2.4M |
| Operating income | -$3.2M | -$1.8M | -$3.8M | $18.1M | — | -$1.1M |
- Revenue -1% vs prior quarter ($3.4M vs $3.4M).
- Gross margin 26.7% (was 37.1% prior quarter).
- Operating margin compressed to -94.4%.
Yearly (6y)
| 2025 | 2024 | |
|---|---|---|
| Revenue | $6.5M | $0.0M |
| Op margin | -174.6% | — |
| Net income | -$45.0M | -$43.1M |
| Gross margin | 23.4% | — |
| Gross profit | $1.5M | $0.0M |
| Operating income | -$11.4M | $0.0M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-24 · SRX Global Makes Investment in Onconetix
2026-09-03 · SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
2026-08-14 · SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ...
2026-08-06 · SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
2026-08-04 · SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics
2026-08-04 · SRX Global Acquires Stake in Vistagen Therapeutics
Price (daily)
Full chart · RSI · MACD · patterns